OCULIS ANNOUNCES FDA IND CLEARANCE ENABLING ACCELERATION OF PRIVOSEGTOR DEVELOPMENT PROGRAM IN ACUTE MULTIPLE SCLEROSIS RELAPSES

Reuters · 2d ago

Please log in to view news